Skip to content
Home/Companies/Biotech/Jennewein Biotechnologie

Jennewein Biotechnologie

Biotech·Germany·Exited 2020·Held 8yr
Entry
2012
Hold
8yr
Exit
2020

Who owns Jennewein Biotechnologie?

Jennewein Biotechnologie was owned by Bioventure Management through Bioventure Club Deals (2011 vintage) from 2012 to 2020, exited via Trade Sale.

Buyer identity and MOIC available on Pro.

Hand-verified · updated 2026-08-10

Bioventure Management
Investor
Bioventure Management
Bioventure Club Deals · 2011 · Life Sciences VC

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2020

More from Bioventure Club Deals

Other portfolio companies in the same fund.

DiaMonTech
DiaMonTech
Active
MedTechGermany· 2025
Repairon
Repairon
Active
BiotechGermany· 2025
Provirex
Provirex
Active
BiotechGermany· 2022
Aphaia Pharma
Active
PharmaSwitzerland· 2018
Aptarion Biotech
Aptarion Biotech
Active
BiotechGermany· 2017
Euroimmun
Exited 2017
MedTechGermany· 2013
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Jennewein Biotechnologie

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Jennewein Biotechnologie.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue